Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From ANGLE plc
With approvals looming over the next few months, Angle spoke to Medtech Insight to probe deeper about its presentation at the 2021 Jefferies Healthcare Conference.
Angle PLC has published half year interim results which indicate it will capitalize on a new liquid biopsy market.
Following a successful fundraise, Angle is poised to further commercialize its proprietary cell-catching technology for cancer diagnosis
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Other Names / Subsidiaries
- Axela Inc.